Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:CLXPFOTCMKTS:HCCCNASDAQ:IPXXNYSEARCA:TGR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCLXPFCybin$8.15-5.0%$7.52$0.49▼$3.38$1.21BN/A551,962 shs184,167 shsHCCCHealthcare Capital$0.00$8.20▼$14.78$437.87MN/A410,825 shs376,700 shsIPXXInflection Point Acquisition Corp. II$11.19-12.1%$10.89$9.24▼$15.25$349.53M0.1792,901 shs3.35 million shsTGRiShares Target Date Retirement$10.55$0.00$33.34▼$34.24$303.31M0.02195,767 shs3,700 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCLXPFCybin0.00%+4.76%+1.12%+21.28%+2,907.38%HCCCHealthcare Capital0.00%0.00%0.00%0.00%0.00%IPXXInflection Point Acquisition Corp. II0.00%-7.87%+38.60%+87.98%+5.52%TGRiShares Target Date Retirement0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCLXPFCybinN/AN/AN/AN/AN/AN/AN/AN/AHCCCHealthcare CapitalN/AN/AN/AN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/AN/AN/AN/ATGRiShares Target Date RetirementN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCLXPFCybin 0.00N/AN/AN/AHCCCHealthcare Capital 0.00N/AN/AN/AIPXXInflection Point Acquisition Corp. II 4.00Strong BuyN/AN/ATGRiShares Target Date Retirement 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCLXPFCybin$680K1,780.99N/AN/A$0.44 per share18.52HCCCHealthcare CapitalN/AN/AN/AN/A$0.06 per shareN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/AN/ATGRiShares Target Date RetirementN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCLXPFCybin-$24.42M-$0.24N/AN/AN/AN/AN/AN/AN/AHCCCHealthcare CapitalN/AN/A0.00N/AN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/A0.00∞N/AN/AN/AN/AN/ATGRiShares Target Date RetirementN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCLXPFCybinN/AN/AN/AN/AN/AHCCCHealthcare CapitalN/AN/AN/AN/AN/AIPXXInflection Point Acquisition Corp. IIN/AN/AN/AN/AN/ATGRiShares Target Date RetirementN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCLXPFCybinN/A13.5713.57HCCCHealthcare CapitalN/A1.901.90IPXXInflection Point Acquisition Corp. IIN/AN/AN/ATGRiShares Target Date RetirementN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCLXPFCybin0.01%HCCCHealthcare Capital70.49%IPXXInflection Point Acquisition Corp. IIN/ATGRiShares Target Date Retirement62.30%Insider OwnershipCompanyInsider OwnershipCLXPFCybinN/AHCCCHealthcare CapitalN/AIPXXInflection Point Acquisition Corp. II20.00%TGRiShares Target Date RetirementN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCLXPFCybin50148.60 millionN/ANot OptionableHCCCHealthcare Capital234.37 millionN/ANot OptionableIPXXInflection Point Acquisition Corp. IIN/A31.25 million25.00 millionNot OptionableTGRiShares Target Date RetirementN/A28.75 millionN/ANot OptionableTGR, CLXPF, HCCC, and IPXX HeadlinesRecent News About These CompaniesiShares LifePath Target Date 2070 ETFApril 3, 2025 | markets.businessinsider.comThe Hidden Risks of Target Date Funds: Why Your Retirement Savings Could Be at RiskFebruary 18, 2025 | msn.comVanguard to pay more than $100M over target-date fund violationsJanuary 17, 2025 | investmentnews.comIVanguard fined more than $100 million by SEC over violations involving target date retirement fundsJanuary 17, 2025 | nbcnews.comRetirees: 4 Target-Date Retirement ETFs That Make Managing Your Portfolio a BreezeDecember 12, 2024 | 247wallst.comIshares Lifepath Target Date 2070 Etf Share Price (ITDJ.US)November 21, 2024 | lse.co.ukVanguard Settlement in Target-Date Fund Case Could Come in a WeekNovember 6, 2024 | barrons.comKKR sets its sights on 401(k) plans via target-date fundsOctober 26, 2024 | pionline.comPMoney expert Clark Howard says this brilliant retirement strategy is like hitting “the easy button”October 12, 2024 | msn.comVanguard Reaches Proposed Settlement in Target-Date Sell-Off CaseSeptember 27, 2024 | thinkadvisor.comTVanguard to Settle Target-Date Fund LawsuitSeptember 27, 2024 | msn.comUS Retirement Assets Hit Record $40TSeptember 21, 2024 | planadviser.comPRetirement income and managed accounts are key 401(k) advisor trends: T. Rowe PriceSeptember 19, 2024 | benefitspro.comBFive Great Target Date Funds for Your Retirement PortfolioSeptember 18, 2024 | msn.comWhy target date strategies miss the markSeptember 17, 2024 | crainsgrandrapids.comCDon't make this $130,000 mistake when rolling over a retirement account, Vanguard warnsSeptember 15, 2024 | businessinsider.comThe Good, Bad And Ugly Of Target-Date FundsSeptember 15, 2024 | fa-mag.comFCelebrating Our Retirement System, And A Call To ActionSeptember 2, 2024 | forbes.comI'm 40 and Just Opened an IRA. Is My Retirement Doomed?August 29, 2024 | fool.comGen Xers are nearing retirement. Here’s why many are more at risk of running short of money than younger colleaguesAugust 21, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTGR, CLXPF, HCCC, and IPXX Company DescriptionsCybin OTCMKTS:CLXPF$8.15 -0.43 (-5.01%) As of 06/27/2025Cybin Inc., a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.Healthcare Capital OTCMKTS:HCCCHealthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.Inflection Point Acquisition Corp. II NASDAQ:IPXX$11.18 -1.55 (-12.14%) As of 06/27/2025Inflection Point Acquisition Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2023 and is based in New York, New York.iShares Target Date Retirement NYSEARCA:TGRiShares Target Date Retirement Income ETF, formerly iShares S&P Target Date Retirement Income Index Fund (the Fund), is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Target Date Retirement Income Index. The Index seeks to represent investment opportunity generally available in target date funds through an asset allocation, which targets an immediate retirement horizon. The Index is designed to measure the performance of an investable asset allocation strategy that meets the investment objectives of investors nearing or currently in retirement. The Fund's investment adviser is BlackRock Fund Advisors. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Alphabet’s Waymo and Services Beginning to Feel the Pressure? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
